Search Within

Sergio Andres Giralt

Formats
  1. Meeting Abstract (632)
  2. Journal Article (373)
  3. Research Letter (17)
  4. Review (15)
  5. Guidelines (5)
  6. Editorial (4)
  7. Book Section (3)
  8. Correspondence (3)
Groups
  1. Bone Marrow Transplant (1052)
  2. Center for Hematologic Malignancies (1052)
  3. Department of Medicine (1052)
  4. Hematologic Malignancies, Division of (1052)
  5. Survivorship Research (686)
  6. CTCR Scholars (541)

More Groups

People
  1. Miguel-Angel Perales (422)
  2. Sean Devlin (372)
  3. Gunjan Shah (298)
  4. Michael Scordo (267)
  5. Heather Landau (253)
  6. Ann Jakubowski (240)

More People

Years
  1. 2025 (11)
  2. 2024 (55)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (304)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (384)
  2. American Society of Hematology (337)
  3. Nature Publishing Group (108)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1052)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Successful personalization of propylene glycol free melphalan (PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT) using pharmacokinetic (PK)-directed dosing
    Meeting Abstract

    Shah, G. L.; Lin, A.; Kamrowski, A.; Carino, C. A.; Schofield, R.; Devlin, S. M.; Bhatt, V.; Proli, A. J.; Chung, D. J.; Dahi, P. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Transplant characteristics and outcomes of Philadelphia (Ph)-like acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Anagnostou, T.; Maloy, M. A.; Patnaik, M. M.; Arcila, M. E.; Gomez Arteaga, A.; Cho, C.; Dahi, P. B.; Gyurkocza, B.; Perales, M.; Ponce, D. M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Improved quality of life with interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) in older patients with multiple myeloma (MM)
    Meeting Abstract

    Shah, G. L.; Murata, K.; Holder, J.; Marcello, L.; Cho, S.; Hoover, E.; Chung, D. J.; Dahi, P. B.; Lahoud, O. B.; Scordo, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Prospective identification of unrelated donors with low inhibitory donor KIR3DL1- Recipient HLA-B interaction decreases relapse and improves survival after allogeneic hematopoietic cell transplantation for myeloid neoplasia
    Meeting Abstract

    Shaffer, B. C.; Park, S.; Le Luduec, J. B.; Devlin, S. M.; Jakubowski, A. A.; Gyurkocza, B.; Papadopoulos, E. B.; Tamari, R.; Giralt, S. A.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Long-term survival in patients with AML or MDS relapsed after allogeneic hematopoietic cell transplantation: Importance of second cell therapy
    Meeting Abstract

    Zuanelli Brambilla, C.; Ruiz, J. D.; Lobaugh, S. M.; Dahi, P. B.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; Sanchez Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Burden and impact of geriatric syndromes in 2-year, progression-free survivors of older allogeneic hematopoietic cell transplant recipients - A landmark analysis
    Meeting Abstract

    Lin, R. J.; Baser, R. E.; Elko, T. A.; Korc-Grodzicki, B.; Shahrokni, A.; Maloy, M. A.; Young, J. W.; Tamari, R.; Shah, G. L.; Shaffer, B. C.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparing car T cells toxicities grading systems: Application of ASTCT grading system and implications for management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C. W.; Brentjens, R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Targeted conditioning with anti-CD45 iodine (I-131) apamistamab [Iomab-B] leads to high rates of allogeneic transplantation and successful engraftment in older patients with active, relapsed or refractory (rel/ref) AML after failure of chemotherapy and targeted agents: Preliminary midpoint results from the prospective, randomized phase 3 SIERRA trial
    Meeting Abstract

    Gyurkocza, B.; Nath, R.; Stiff, P. J.; Agura, E.; Litzow, M. R.; Tomlinson, B.; Choe, H.; Abhyankar, S.; Seropian, S. E.; Chen, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save